Newsroom

CathNova receives CHF 40,000 from Venture Kick to advance neuromodulation therapy toward clinical validation

01.05.2026

CathNova receives CHF 40,000 from Venture Kick to advance its neuromodulation therapy for preventing ventilator-associated pneumonia in ICU patients. By targeting the root cause of gastric aspiration, the technology aims to improve clinical ... mehr

omenic receives CHF 40,000 from Venture Kick to enhance AI-powered operational decision systems

01.05.2026

omenic receives CHF 40,000 from Venture Kick to advance its AI-powered decision engine for weather-sensitive industries. By simulating scenarios and recommending operational actions, the technology helps sectors like aviation anticipate dis ... mehr

ALP Bio raises USD 2.2M pre-seed to address immunogenicity risk in antibody development

30.04.2026

Swiss biotech startup ALP Bio has raised USD 2.2 million in pre-seed financing to advance its platform combining human immune organoid biology and generative AI, aiming to identify and reduce immunogenicity risk earlier in antibody developm ... mehr

Mehr

Twitter

Youtube

Facebook

 

Medienanfragen

Für Presseanfragen, schreiben Sie bitte unserem KommunikationsteamFalls Sie generelle Fragen zu Venture Kick haben, gehen Sie bitte auf unsere Kontaktseite.

Erfahren Sie mehr über Venture Kick oder laden Sie sich unseren letzten Jahresbericht herunter für detaillierte Informationen.